日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Independent Risk Factors and a New Nomogram for Predicting Breast Cancer Risk for Bone Metastasis in Chinese Women: A Retrospective Study with External Validation

中国女性乳腺癌骨转移风险预测的独立危险因素及新的列线图：一项回顾性研究及外部验证

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm15062324
Huang, Yunfei; Ge, Tianjiao; Song, Heng; Zhang, Wenjia; Wang, Meiqi; Song, Zhenchuan
肿瘤免疫
肿瘤
乳腺癌
发表日期：2026
文献求助 收藏

Multidimensional cell-free DNA fragmentomics enables early detection of breast cancer

多维无细胞DNA片段组学可实现乳腺癌的早期检测

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-02190-8
Yang, Lixian; An, Mengyang; Song, Heng; Zhang, Xuan; Wang, Meiqi; Yang, Liu; Wang, Xinle; Yang, Hua; Hong, Xinyue; Song, Zhenchuan
细胞生物学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Eribulin plus Pyrotinib in Trastuzumab-Resistant, HER2-Positive Advanced Breast Cancer: A Single-Arm, Multicenter Phase II Trial (EPIC Trial)

Eribulin 联合 Pyrotinib 治疗曲妥珠单抗耐药、HER2 阳性晚期乳腺癌：一项单臂、多中心 II 期试验（EPIC 试验）

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S547569
Li, Ruoyang; Wang, Meiqi; Kong, Xiangshun; Ma, Jie; Qi, Xiuheng; Song, Zhenchuan
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

A retrospective study on axilla treatment for breast cancer with sentinel lymph node micrometastases

一项关于乳腺癌前哨淋巴结微转移患者腋窝治疗的回顾性研究

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000045011
Zhao, Xueyi; Yang, Liu; Ge, Tianjiao; Huang, Yunfei; Li, Xiaolong; Wang, Quanle; Song, Zhenchuan
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Bioinformatic analysis reveals an association between Metadherin with breast cancer prognosis and tumor immune infiltration

生物信息学分析揭示了Metadherin与乳腺癌预后和肿瘤免疫浸润之间的关联。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-52403-x
Yang, Lixian; Yang, Liu; Kong, Fanting; Zhang, Shiyu; Pu, Pengpeng; Li, Xiaowei; Song, Zhenchuan
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2024
文献求助 收藏

LncRNA DDX11-AS1 promotes breast cancer progression by targeting the miR-30c-5p/MTDH axis.

LncRNA DDX11-AS1 通过靶向 miR-30c-5p/MTDH 轴促进乳腺癌进展

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-78413-3
Li Yanting, Zhou Mengsi, Yang Liu, Liu Shuo, Yang Lixian, Xu Bin, Li Xiaolong, Zhao Haijun, Song Zhenchuan
肿瘤
乳腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

The prognostic analysis of further axillary dissection in breast cancer with 1-2 positive sentinel lymph nodes undergoing mastectomy

对接受乳房切除术且前哨淋巴结阳性（1-2个）的乳腺癌患者进行腋窝淋巴结清扫术的预后分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1406981
Zhao, Xueyi; Yang, Liu; Cao, Congbo; Song, Zhenchuan
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

The role of ATP6V0D2 in breast cancer: associations with prognosis, immune characteristics, and TNBC progression.

ATP6V0D2 在乳腺癌中的作用：与预后、免疫特征和 TNBC 进展的关系

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1511810
Zhang Jingyu, Yang Lixian, Xu Bin, Ji Haibo, Liu Shuo, Wang Xiaohan, Li Xiaolong, Wang Quanle, Song Zhenchuan
肿瘤
乳腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study

利博西尼联合内分泌治疗HR+/HER2-晚期乳腺癌中国绝经前和绝经后女性患者：一项II期随机研究的主要结果

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.7408
Shao, Zhimin; Tong, Zhongsheng; Liu, Qiang; Li, Wei; Cai, Li; Shen, Kunwei; Li, Huiping; Wang, Chuan; Yang, Jin; Song, Zhenchuan; Wang, Shui; Luo, Ting; Zhao, Wenhe; Wang, Haibo; Pan, Yueyin; Nie, Jianyun; Zeng, Xiaohua; Bai, Yanqing; Chiang, Wendy; Guarnaccia, Valeria; Bi, Yu; Xu, Binghe
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial

吡咯替尼联合卡培他滨治疗曲妥珠单抗耐药、HER2阳性晚期乳腺癌（PICTURE）：一项单臂、多中心II期试验

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-023-02999-0
Cao, Jun; Teng, Yuee; Li, Huiping; Zhang, Lili; Ouyang, Quchang; Xie, Weimin; Pan, Yueyin; Song, Zhenchuan; Ling, Xiaoling; Wu, Xiaohong; Xu, Jingwei; Li, Li; Ren, Liping; Wang, Hong; Zhou, Dongxian; Luo, Jing; Hu, Xichun
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏